Showing results (921-930 of 1,124) with videos related to

Sort By:
Pageof 113
Bioorganic & Medicinal Chemistry Letters|August 13, 2013
Octahydropyrrolo[3,4-c]pyrrole negative allosteric modulators of mGlu1Jason T Manka, Alice L Rodriguez, Ryan D Morrison, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 5, 2019
Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New ZealandLuis Calzadilla-Bertot, Gary P Jeffrey, Bryon Jacques, et al.
The American Journal of Medicine|December 4, 2018
Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized TrialTed R Mikuls, T Craig Cheetham, Gerald D Levy, et al.
ACS Chemical Neuroscience|September 20, 2011
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addictionCraig W Lindsley, Brittney S Bates, Usha N Menon, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2022
Discovery of a potent M5 antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonistsDouglas L Orsi, Andrew S Felts, Alice L Rodriguez, et al.
ACS Medicinal Chemistry Letters|January 12, 2013
Discovery of N-Aryl Piperazines as Selective mGlu(5) Potentiators with Efficacy in a Rodent Model Predictive of Anti-Psychotic ActivityYa Zhou, Jason T Manka, Alice L Rodriguez, et al.
Research Square|April 16, 2025
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy ParticipantsAlexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 4, 2008
Toward an improved prediction of human in vivo brain penetrationS G Summerfield, A J Lucas, R A Porter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2020
Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver diseaseLeon A Adams, Zhengyi Wang, Chris Liddle, et al.
Alzheimer'S Research & Therapy|July 2, 2025
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participantsAlexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Pageof 113